Peptide Library

Claim being evaluated

Is safe for human administration

A claim to investigate, not an established benefit. Each outcome below is assessed separately.

What the evidence suggests

Adverse events, serious adverse events and discontinuations: No eligible human study addressing this question was found. This is not evidence that there is no effect.

Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated by rule (no eligible human study was found), not reviewed by a person.

Certainty by outcome

Adverse events, serious adverse events and discontinuations

Insufficient information to assess

Safety outcome · 0 studies

Not enough evidence to tell

No eligible human study addressing this question was found. This is not evidence that there is no effect.

Reviewers’ note: No eligible human study addressing this question was found. This is not evidence that there is no effect.

How the certainty was judged
GRADE domain judgments
DomainJudgmentWhy
Starting level—
Risk of bias—
Inconsistency—
Indirectness—
Imprecision—
Publication bias—

Included studies

    Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · GRADE (handbook, 2013) · Automated by rule (no eligible human study was found), not reviewed by a person.

    The questions and the studies screened

    Population, intervention, comparator and outcome (PICO), and why each study was or wasn’t eligible.

    Population: Any human population studied · Intervention: TB-500 (the thymosin beta-4 fragment) · Comparator: Placebo, another treatment or none · Outcome: Adverse events, serious adverse events and discontinuations

    Version history

    • Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated by rule (no eligible human study was found), not reviewed by a person.

    How claims are assessed

    These assessments describe published research. Records marked automated were produced by AI under the published methodology and have not been reviewed by a person; they can contain errors. None of this is medical advice, not a statement about any product’s safety for human use, and not a regulatory approval. Peptide Library’s vendor and partner relationships play no part in them (editorial independence).